期刊文献+

经皮心室辅助装置在高危冠状动脉介入治疗中的应用进展 被引量:2

Application progress of percutaneous ventricular assist devices for high-risk percutaneous coronary intervention therapy
原文传递
导出
摘要 接受高危冠状动脉介入治疗的患者,出现血流动力学崩溃的风险较高,经皮心室辅助装置可以改善血流动力学,与主动脉内球囊反搏相比能提供术中完全的循环支持,因此有一定的应用价值。目前,国外心导管室主要应用的两种经皮心室辅助装置,分别为Tandem Heart经皮心室辅助装置和Impella Recover LP 2.5系统,本文就其在高危冠状动脉介入治疗中的应用现状以及临床研究进展进行了综述。 Percutaneous ventricular assist devices (pVADs) can improve hemodynamic parameters and provide the important role in patients with higher risk undergoing percutaneous coronary intervention (PCI). Current pVADs include the TandemHeart and the Impella Recover LP 2.5 System. This review discussed clinical utility and clinical trials of pVADs.
出处 《中华临床医师杂志(电子版)》 CAS 2015年第13期130-133,共4页 Chinese Journal of Clinicians(Electronic Edition)
关键词 心脏辅助装置 血管成形术 经腔 经皮冠状动脉 IMPELLA RECOVER LP 2.5系统 TandemHeart Heart-assist devices Angioplasty,transluminal,percutaneous coronary TandemHeart Impella Recover LP 2.5 system
  • 相关文献

参考文献24

  • 1Andersson H,Sejersten M,Clemmensen P,et al.Prognosis and high-risk complication identification in unselected patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention[J].Acute Card Care,2010,12(3):102-108.
  • 2Ferrari M,Kruzliak P,Spiliopoulos K.An insight into short-and long-term mechanical circulatory support systems[J].Clin Res Cardiol,2015,104(2):95-111.
  • 3Mwesige J,Uriel N,Singh M,et al.Saving the patient with post-ACS cardiogenic shock[J].Minerva Cardioangiol,2013,61(3):281-293.
  • 4Westaby S,Kharbanda R,Banning AP.Cardiogenic shock in ACS.Part 1:prediction,presentation and medical therapy[J].Nat Rev Cardiol,2011,9(3):158-171.
  • 5Tsao NW,Shih CM,Yeh JS,et al.Extracorporeal membrane oxygenation-assisted primary percutaneous coronary intervention may improve survival of patients with acute myocardial infarction complicated by profound cardiogenic shock[J].J Crit Care,2012,27(5):530.e1-11.
  • 6Goyal D,Nadar SK,Wrigley B,et al.Successful use of intra-aortic counter pulsation therapy for intractable ventricular arrhythmia in patient with severe left ventricular dysfunction and normal coronary arteries[J].Cardiol J,2010,17(4):401-403.
  • 7Minha S,Barbash IM,Dvir D,et al.Correlates for mortality in patients presented with acute myocardial infarct complicated by cardiogenic shock[J].Cardiovasc Revasc Med,2014,15(1):13-17.
  • 8Mahmoudi M,Hauville C,Gaglia MA Jr,et al.The impact of intra-aortic balloon counter-pulsation on in-hospital mortality in patients presenting with anterior ST-elevation myocardial infarction without cardiogenic shock[J].Cardiovasc Revasc Med,2012,13(6):328-330.
  • 9Alam R,Anantharaman R.Use of IABP in contrast media-induced anaphylactic shock:the ultimate lifesaver[J].BMJ Case Rep,2013.
  • 10Akhondi AB,Lee MS.The use of percutaneous left ventricular assist device in high-risk percutaneous coronary intervention and cardiogenic shock[J].Rev Cardiovasc Med,2013,14(2/4):e144-149.

同被引文献13

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部